🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Caitlin Molczyk

Nebraska Medical Center

ORCID: 0000-0001-6397-1099

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer”.

Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer

Cancer Letters(2023)10.1016/j.canlet.2023.216185

N/A

0DataRank · unranked

34 citations

Caitlin Molczyk, Abhilasha Purohit, Sugandha Saxena, Reegan Sturgeon, Bhavana J. Davé +4 more

Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.25.661585

N/A

0DataRank · unranked

1 citations

Reegan Sturgeon, Sugandha Saxena, Esther Johnsson, Rakesh Bhatia, Namita Bhyrabhatla +4 more

Neutrophil Dynamics Contribute to Disease Progression and Poor Survival in Pancreatic Cancer

Cancers(2025)10.3390/cancers17213541

N/A

0DataRank · unranked

0 citations

Paran Goel, Caitlin Molczyk, Ridhi Bhola, Paul M. Grandgenett, Michael A. Hollingsworth +2 more